Moderna Inc MRNA

NASDAQ US Health Care Biotechnology

$54.82 ▼ -5.35% ($-3.10)

Index member: S&P 500

📅 Earnings This Week

Open $57.85

Prev Close $57.92

Day Range $54.71 – $59.49

52W Range $22.28 – $85.60

Market Cap $21.75B

Beta 0.88

EPS (TTM) $-8.15

📋 Company Profile

Industry	Biotechnology
Sector	Health Care
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2018-12-07
Shares Out.	396,790,000
Website	modernatx.com/ ↗
Phone	13026587581
Employees	4,700
Revenue	$389.0M
Gross Profit	-$566.0M
Net Income	-$1.34B
Free Cash Flow	-$1.60B
Total Assets	$11.49B
Total Liabilities	$4.08B
Equity	$7.41B

About Moderna Inc

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Moderna Inc is a publicly traded company under the ticker symbol MRNA on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.